Loading live market data…

Purple Innovation, Inc.

NASDAQ:PRPL

$0.313 USD

-$0.01 (-4.49%)

Volume
241.28K
Average Volume
363.99K
Market Capitalization
$34.06M
P/E Ratio
-0.54
Dividend Yield
0.00%
Price Target
$1.50
Year High
$1.26
Year Low
$0.30
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.24
Source Headline
After Plunging 27.4% in 4 Weeks, Here's Why the Trend Might Reverse for Purple Innovation (PRPL)

Purple Innovation (PRPL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

zacks.com - 2026-04-30 10:35:26

Purple Innovation, Inc. (PRPL) Q1 2026 Earnings Call Transcript

Purple Innovation, Inc. (PRPL) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-28 17:11:34

Purple Innovation Reports First Quarter 2026 Results

Showroom Comps up 7.0%, Marking the Third Consecutive Quarter of Positive Comps E-commerce Trends Improve Sequentially Early Traction from Purple Royale at Mattress Firm Supports Premium Momentum and Wholesale Growth Reaffirms Full Year EBITDA Guidance; Positioned for Improving Performance in Second Quarter LEHI, Utah, April 28, 2026 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple"), a comfort innovation company whose mattresses promise to give you "less pain, better sleep," today announced results for the first quarter ended March 31, 2026. "During the first quarter, we continued to build on the progress we made at the end of last year, with improving consistency across our business and solid performance in our showroom and wholesale channels," said Rob DeMartini, CEO of Purple Innovation.

prnewswire.com - 2026-04-28 08:00:00

Purple Innovation Announces CFO Transition

Robert (Bob) Lucian, Former La-Z-Boy CFO, Appointed Chief Financial Officer Todd Vogensen to Depart Effective May 1, 2026 LEHI, Utah, April 28, 2026 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple"), a comfort innovation company whose mattresses promise to give you "less pain, better sleep," today announced that Chief Financial Officer Todd Vogensen will depart the Company effective May 1, 2026, to pursue another opportunity. The Company also announced the appointment of Robert (Bob) Lucian, a seasoned public company finance executive and former Chief Financial Officer of La-Z-Boy Incorporated, as Chief Financial Officer, effective April 27, 2026.

prnewswire.com - 2026-04-28 07:59:00

Purple Innovation to Report First Quarter 2026 Results on April 28, 2026

LEHI, Utah, April 21, 2026 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) ("Purple"), a comfort innovation company whose mattresses promise to give you "less pain, better sleep," will report first quarter 2026 financial results on Tuesday, April 28, 2026 at approximately 8:00 a.m. ET. The Company will hold a conference call that day at 8:30 a.m.

prnewswire.com - 2026-04-21 08:00:00

Bet on 5 Top-Ranked Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Keurig Dr Pepper, Purple Innovation, H&R Block, Peloton Interactive and Allbirds.

zacks.com - 2026-04-15 09:31:14

Get PRPL Insider Trade Alerts

PRPL Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$0.00

0 analysts

All Time

$2.47

5 analysts

PRPL Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-04-29 UBS Maintain Neutral Neutral
2026-04-29 Keybanc Downgrade Overweight Sector Weight
2026-04-01 UBS Maintain Neutral Neutral
2025-03-26 Wedbush Maintain Neutral Neutral
2024-09-04 Wedbush Downgrade Outperform Neutral
2024-08-06 Craig-Hallum Maintain Hold Hold
2024-05-08 Wedbush Maintain Outperform Outperform
2024-03-21 Roth MKM Maintain Buy Buy
2024-03-13 Wedbush Maintain Outperform Outperform
2024-03-13 Craig-Hallum Maintain Hold Hold
2024-03-13 Roth MKM Upgrade Neutral Buy
2024-03-07 Roth MKM Maintain Neutral Neutral
2024-01-24 Keybanc Maintain Overweight Overweight
2024-01-24 Wedbush Maintain Outperform Outperform
2023-11-13 Oppenheimer Downgrade Outperform Perform
2023-11-10 Keybanc Maintain Overweight Overweight
2023-11-10 Wedbush Maintain Outperform Outperform
2023-11-10 Craig-Hallum Downgrade Buy Hold
2023-08-25 Oppenheimer Maintain Outperform Outperform
2023-08-10 Wedbush Maintain Outperform Outperform
2023-04-14 Wedbush Maintain Outperform Outperform
2023-03-21 UBS Maintain Neutral Neutral
2023-02-01 Keybanc Maintain Overweight Overweight
2023-01-12 Keybanc Maintain Overweight Overweight
2022-11-10 Craig-Hallum Upgrade Hold Buy
2022-09-20 Wedbush Maintain Outperform Outperform
2022-09-20 Keybanc Maintain Overweight Overweight
2022-03-28 Keybanc Maintain Overweight Overweight
2022-03-02 Roth Capital Downgrade Buy Neutral
2022-03-02 Keybanc Maintain Overweight Overweight
2021-12-14 Keybanc Maintain Overweight Overweight
2021-12-14 Wedbush Maintain Outperform Outperform
2021-11-10 Raymond James Downgrade Outperform Market Perform
2021-11-10 Keybanc Maintain Overweight Overweight
2021-11-10 UBS Downgrade Buy Neutral
2021-11-10 Truist Securities Downgrade Buy Hold
2021-11-10 B. Riley Securities Downgrade Buy Neutral
2021-11-08 B of A Securities Downgrade Buy Underperform
2021-10-04 Keybanc Maintain Overweight Overweight
2021-09-28 Craig-Hallum Downgrade Buy Hold
2021-08-11 Roth Capital Maintain Buy Buy
2021-07-01 Roth Capital Maintain Buy Buy
2021-06-30 Raymond James Maintain Outperform Outperform
2021-05-18 Raymond James Maintain Outperform Outperform
2021-05-18 Roth Capital Maintain Buy Buy
2021-03-05 KeyBanc Maintain Overweight Overweight
2021-03-05 Keybanc Maintain Overweight Overweight
2021-03-05 Raymond James Maintain Outperform Outperform
2021-03-04 KeyBanc Maintain Overweight Overweight
2021-02-09 Keybanc Maintain Overweight Overweight
2021-02-09 KeyBanc Maintain Overweight Overweight
2021-02-08 KeyBanc Maintain Overweight Overweight
2021-01-14 KeyBanc Maintain Overweight Overweight
2021-01-13 Keybanc Maintain Overweight Overweight
2020-11-10 KeyBanc Maintain Overweight Overweight
2020-11-10 Keybanc Maintain Overweight Overweight
2020-10-26 Raymond James Maintain Outperform Outperform
2020-08-14 KeyBanc Maintain Overweight Overweight
2020-08-14 Raymond James Maintain Outperform Outperform
2020-08-14 Keybanc Maintain Overweight Overweight
2020-08-03 Craig-Hallum Maintain Buy Buy
2020-07-24 KeyBanc Maintain Overweight Overweight
2020-07-24 Keybanc Maintain Overweight Overweight
2020-06-16 B. Riley FBR Maintain Buy Buy
2020-06-11 Raymond James Maintain Outperform Outperform
2020-06-10 Keybanc Maintain Overweight Overweight
2020-06-10 KeyBanc Maintain Overweight Overweight
2020-05-12 Wedbush Maintain Outperform Outperform
2020-05-12 Keybanc Maintain Overweight Overweight
2020-05-12 Raymond James Maintain Outperform Outperform
2020-05-12 KeyBanc Maintain Overweight Overweight
2020-03-31 Keybanc Maintain Overweight Overweight
2020-03-31 KeyBanc Maintain Overweight Overweight
2020-03-10 Wedbush Maintain Outperform Outperform
2020-02-14 Oppenheimer Maintain Outperform Outperform
2020-01-27 KeyBanc Maintain Overweight Overweight
2020-01-27 Keybanc Maintain Overweight Overweight
2020-01-16 Raymond James Maintain Outperform Outperform
2020-01-14 Wedbush Maintain Outperform Outperform
2019-12-19 Bank of America Maintain Buy Buy
2019-11-26 Raymond James Maintain Outperform Outperform
2019-11-25 KeyBanc Maintain Overweight Overweight
2019-10-28 Roth Capital Maintain Buy Buy
2019-09-23 Wedbush Maintain Outperform Outperform
2018-11-15 Wedbush Maintain Outperform Outperform
2018-08-10 Wedbush Maintain Outperform Outperform
2018-04-11 Wedbush Maintain Outperform Outperform